US Archives - Page 78 of 119 - European Medical Journal

Oral Healthcare Needs in Canadian Rheumatic Patients

Patients with autoimmune rheumatic diseases (RD) have a high prevalence of oral manifestations and/or oral side effects from…

Quality Improvement for Vasculitis Vaccination

Vasculitis is an umbrella term encompassing approximately 20 rare but serious diseases that are characterized by autoimmune inflammation…

Early Oseltamivir Treatment Reduces Mortality in Patients Hospitalized with Flu

Initiating oseltamivir treatment on the day of hospital admission significantly reduces the severity of illness and risk of death in adults hospitalized with influenza.

Blood Pressure Variability and Cognitive Decline in Older Adults

Findings revealed that higher blood pressure variability, particularly in systolic blood pressure, was associated with lower cognitive scores at the final follow-up.

Efficacy of Selpercatinib Beyond NSCLC Progression

Selpercatinib, a targeted RET kinase inhibitor, has demonstrated continued efficacy in treating RET fusion-positive non–small cell lung cancer (NSCLC) even after disease progression.

Study Links Early β-lactam Use to Lower Sepsis Deaths

A recent study sheds light on the timing of antibiotic administration in patients with suspected sepsis, suggesting that giving β-lactam antibiotics before vancomycin may lead to better outcomes.

Axial Spondyloarthritis More Severe in Black Americans

A recent study conducted across five centers in Shelby County, Tennessee, reveals concerning disparities in the diagnosis and severity of axial spondyloarthritis (axSpA) in Black Americans.

Global Consensus Forms on Low-Dose Oral Minoxidil

An international expert panel of 43 dermatologists has established an expert consensus on the off-label use of low-dose oral minoxidil (LDOM) for treating hair loss.

Breakthroughs in IgG4-Related Autoimmune Neuropathies

A recently published review article has shed light on significant breakthroughs in the understanding and treatment of IgG4-mediated autoimmune diseases, particularly in the realm of autoimmune neuropathies.

Functional Outcomes After Respiratory Failure Explored

Respiratory failure impacts millions annually in the U.S., leaving many survivors with lasting physical, cognitive, and quality-of-life impairments.